Mutations in pleiotropic lipid regulators involved in sphingolipid and glycerophospholipid metabolism, PLA2G6, have been found to cause levodopa-responsive parkinsonism with dystonia (Doherty and Hardy, 2013). The gene discussed is PLA2G6; the disease is Parkinson disease.